The Annual General Meeting of Baloise Holding Ltd voted in favour of all the proposals on the agenda put forward by the Board of Directors. The shareholders approved the Company’s 2024 management report and separate and consolidated annual financial statements, and formally approved the actions of the members of the Board of Directors and management team.
The Annual General Meeting also approved the dividend proposed by the Board of Directors. As a result, a gross dividend of CHF 8.10 per share will be paid from distributable profit. This equates to a dividend increase of CHF 0.40 per share.
Dr Thomas von Planta, Chairman of the Board of Directors, commented on the planned merger with Helvetia in his speech, saying “We will bundle our Company’s strengths with those of Helvetia, a merger of equals that represents a strategically compelling move. It is also a project for the generations that will take us into a new league. The merged organisation will be the second-largest Swiss insurance group and one of Europe’s leading insurers. We will become the largest insurance employer in Switzerland and will create long-term stability for all stakeholders.” On that note, he referred to the upcoming Extraordinary General Meeting on 23 May 2025.
The Annual General Meeting confirmed the election of André Helfenstein and Vincent Vandendael as new members of the Board of Directors of Baloise Holding Ltd. These additional appointments further strengthen the insurance and financial markets expertise of the Board of Directors and its experience in these fields.
Dr Karin Lenzlinger Diedenhofen and Christoph Mäder were re-elected as members of the Remuneration Committee, while Dr. Maya Bundt and Vincent Vandendael were newly elected to the Remuneration Committee.
After eleven and seven successful years respectively on the Board of Directors of Baloise Holding Ltd, Christoph Gloor and Professor Hans-Jörg Schmidt-Trenz did not stand for re-election. Dr Thomas von Planta, Chairman of the Board of Directors, expressed his gratitude to them for their many years of invaluable work on the Board of Directors.
A total of 1,001 shareholders attended the Annual General Meeting at the Messe Basel exhibition centre, representing 26,432,791 votes (57.7 per cent of the share capital).
The full speech in German by Dr Thomas von Planta can be downloaded from www.baloise.com/annual-general-meeting and can be watched as a video stream from 28 April 2025 at www.youtube.com/BaloiseGroup.
- Tuesday, 29 April 2025: Ex-dividend date
- Friday, 2 May 2025: Dividend payment date
- Friday, 23 May 2025: Extraordinary General Meeting Baloise Holding AG
- Wednesday, 10 September 2025: 2025 half-year financial results
This document is not an offer of merger consideration shares in the United States. Neither the merger consideration shares nor any other securities have been or will be registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”), and neither the merger considerations shares nor any other securities may be offered, sold or delivered within or into the United States, except pursuant to an applicable exemption of, or in a transaction not subject to, the Securities Act. This document must not be forwarded, distributed or sent, directly or indirectly, in whole or in part, in or into the United States.
This document is for information purposes only and does not constitute an offer to sell or an offer or solicitation to buy or subscribe to securities, nor does it constitute financial analysis or advice or a recommendation relating to financial instruments in any member state of the European Union. This document does not constitute and shall not, in any circumstances, constitute a public offering nor an invitation to the public in connection with any offer within the meaning of the Regulation (EU) 2017/1129 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, and repealing Directive 2003/71/EC, as amended (the “Prospectus Regulation”). No action has been or will be taken in any member state of the European Union in relation to the securities to permit a public offering of securities. This document does not constitute a prospectus for the purposes of the Prospectus Regulation.